Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Type 1 Diabetes and Multiple Sclerosis Share General Autoimmunity Genetic Variation.

Genes·2026
Same author

Reduced cyclin D3 expression in erythroid cells protects against malaria.

Nature·2026
Same author

Frailty across Neurological Diseases: Why Sex and Gender Matter.

Annals of neurology·2025
Same author

Evaluation of the Metabolomics Profile in Charcot-Marie-Tooth (CMT) Patients: Novel Potential Biomarkers.

Metabolites·2025
Same author

Silent burden: recognising and managing invisible symptoms in neuromyelitis optica.

Journal of neurology, neurosurgery, and psychiatry·2025
Same author

Treating comorbidities in multiple sclerosis is disease modifying: Yes.

Multiple sclerosis (Houndmills, Basingstoke, England)·2025
Same journal

Correction: Pramesthi et al. Evaluating the Impact of Indonesia's National School Feeding Program (ProGAS) on Children's Nutrition and Learning Environment: A Mixed-Methods Approach. <i>Nutrients</i> 2025, <i>17</i>, 3575.

Nutrients·2026
Same journal

Correction: Huang et al. Correlation Study Between Dietary Behaviors, Lifestyle, and Psychological Problems in Chinese Children Aged 3-7. <i>Nutrients</i> 2025, <i>17</i>, 176.

Nutrients·2026
Same journal

Association of Dietary Animal and Plant Protein Composition with All-Cause Mortality: 24-Year Population-Based Cohort Study.

Nutrients·2026
Same journal

Phytochemistry, Bioavailability, and Molecular Mechanisms Underlying Multitarget Anticancer Activity of <i>Aloe vera</i>.

Nutrients·2026
Same journal

A Comparison of the Interstitial and Blood Glucose Responses Following Consumption of Different Carbohydrate-Containing Beverages in Humans: A Randomised Controlled Trial.

Nutrients·2026
Same journal

Across Kingdoms: The Bacteriome, Mycobiome, and Virome in Autoimmune Diseases: Mechanistic Insights, Therapeutic Perspectives, and the Emerging Role of COVID-19.

Nutrients·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2025

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

3.7K

Propionic Acid Impact on Multiple Sclerosis: Evidence and Challenges.

Lorena Lorefice1, Magdalena Zoledziewska2

  • 1Multiple Sclerosis Center, ASL Cagliari, Department of Medical Sciences and Public Health, Binaghi Hospital, University of Cagliari, via Is Guadazzonis 2, 09126 Cagliari, Italy.

Nutrients
|November 27, 2024
PubMed
Summary
This summary is machine-generated.

Propionic acid, a gut bacteria byproduct, may help manage multiple sclerosis (MS) by regulating the immune system and protecting the nervous system. Further clinical trials are needed to confirm its efficacy and safety for people with MS.

Keywords:
SCFAdietgut microbiotamultiple sclerosispropionic acid

More Related Videos

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

4.1K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.5K

Related Experiment Videos

Last Updated: Jun 6, 2025

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

3.7K
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

4.1K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.5K

Area of Science:

  • Neuroimmunology
  • Microbiome research
  • Metabolic disorders

Background:

  • Multiple sclerosis (MS) is an immune-mediated central nervous system disorder influenced by environmental factors.
  • Gut microbiome alterations and deficiencies in short-chain fatty acids like propionic acid are implicated in MS pathology.
  • Propionic acid exhibits potential immunoregulatory and neuroprotective effects relevant to MS.

Purpose of the Study:

  • To comprehensively review the evidence for propionic acid's role in multiple sclerosis.
  • To analyze the potential benefits of propionic acid supplementation in managing MS.
  • To discuss the challenges and limitations of using propionic acid as a complementary therapy for MS.

Main Methods:

  • Literature review of studies on propionic acid, gut microbiome, and multiple sclerosis.
  • Analysis of preclinical and clinical data regarding propionic acid's effects on immune and nervous systems.
  • Evaluation of proposed mechanisms of action, including immune modulation and barrier integrity.

Main Results:

  • Propionic acid demonstrates immunomodulatory, neuroprotective, and neurogenerative properties.
  • Increased propionic acid levels may counteract inflammation and improve barrier function in MS.
  • Potential benefits include direct immune system regulation and reduced gut and blood-brain barrier permeability.

Conclusions:

  • Propionic acid supplementation shows promise as a complementary strategy for multiple sclerosis.
  • Further large-scale clinical trials are essential to establish efficacy and safety in people with MS.
  • Clarifying propionic acid's role could lead to novel therapeutic approaches for MS management.